What is Wedbush’s Estimate for CRBP FY2029 Earnings?
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) – Stock analysts at Wedbush issued their FY2029 earnings estimates for Corbus Pharmaceuticals in a report issued on Tuesday, May 6th. Wedbush analyst R. Driscoll anticipates that the biopharmaceutical company will post earnings per share of ($4.49) for the year. Wedbush currently has a “Outperform” rating and […]
